Release Date: 13/12/17 11:57 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 412.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%